Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burton R Karger

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|October 17, 2024
ELISA-R: an R-based method for robust ELISA data analysisTaru S Dutt, John S Spencer, Burton R Karger, et al.
Cell Reports|December 14, 2022
Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosisTaru S Dutt, Burton R Karger, Amy Fox, et al.
Vaccine|September 26, 2020
BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosisSangeeta Tiwari, Taru S Dutt, Bing Chen, et al.
Vaccines|April 30, 2021
A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge ModelIzabela K Ragan, Lindsay M Hartson, Taru S Dutt, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|October 17, 2024
ELISA-R: an R-based method for robust ELISA data analysisTaru S Dutt, John S Spencer, Burton R Karger, et al.
Cell Reports|December 14, 2022
Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosisTaru S Dutt, Burton R Karger, Amy Fox, et al.
Vaccine|September 26, 2020
BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosisSangeeta Tiwari, Taru S Dutt, Bing Chen, et al.
Vaccines|April 30, 2021
A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge ModelIzabela K Ragan, Lindsay M Hartson, Taru S Dutt, et al.
Pageof 1